Company Filing History:
Years Active: 2019-2024
Title: David Edward Smolin: Innovator in Recombinant Protein Production
Introduction
David Edward Smolin is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 5 patents to his name, Smolin's work has advanced the understanding and application of mammalian cell systems in producing therapeutic proteins.
Latest Patents
Among his latest patents, Smolin has developed compositions and methods for producing a composition that includes mammalian cells capable of producing recombinant CTLA4-Ig and its variants. This invention not only provides for the production of CTLA4-Ig but also includes methods for mass-producing and purifying this recombinant protein. Additionally, he has focused on the carbohydrate content of CTLA4 molecules, further enhancing the efficacy of these therapeutic agents.
Career Highlights
David Edward Smolin is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the field of biotechnology. His work has been instrumental in developing new therapeutic strategies that leverage recombinant proteins for medical applications.
Collaborations
Throughout his career, Smolin has collaborated with esteemed colleagues such as Kirk J. Leister and Eugene J. Schaefer. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.
Conclusion
David Edward Smolin's contributions to the field of biotechnology, particularly in the production of recombinant proteins, highlight his role as a leading inventor. His patents and ongoing work at Bristol-Myers Squibb Company continue to impact the development of therapeutic solutions.